CervoMed Inc. (CRVO) › Operating Cash FlowCervoMed Inc. (CRVO) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2010: -$1.98M2011: -$12.02M2012: -$4.31M2013: -$1.18M2014: -$9.03M2015: -$5.19M2016: -$10.77M2017: -$12.33M2018: -$10.77M2019: -$9.86M2020: -$13.55M2021: -$14.50M2022: -$2.57M2023: -$7.45M2024: -$16.53M2025: -$23.45M-$23.45M2010Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025-$23.45M-41.9%2024-$16.53M-121.9%2023-$7.45M-189.6%2022-$2.57M+82.3%2021-$14.50M-7.0%2020-$13.55M-37.5%2019-$9.86M+8.5%2018-$10.77M+12.6%2017-$12.33M-14.5%2016-$10.77M-107.7%2015-$5.19M+42.6%2014-$9.03M-662.3%2013-$1.18M+72.5%2012-$4.31M+64.2%2011-$12.02M-507.0%2010-$1.98M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share